Invention Title:

Systems and Methods for Automated Diagnosis of Disease Related Risk Factors in 3D Biomedical Imaging

Publication number:

US20260100267

Publication date:
Section:

Physics

Class:

G16H30/40

Inventors:

Assignee:

Applicant:

Smart overview of the Invention

The application discusses a system utilizing deep learning to detect and classify disease-related risk factors in three-dimensional (3D) biomedical images. This approach aims to automate the identification of biomarkers in various imaging modalities, such as optical coherence tomography (OCT), ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). By leveraging deep neural networks, the system predicts clinically significant biomarkers, enhancing the efficiency and accuracy of disease diagnosis and monitoring.

Background

Biomedical imaging plays a crucial role in clinical care, assisting in the diagnosis and management of various diseases. For instance, OCT images are used in ophthalmology to track retinal conditions like age-related macular degeneration (AMD), while cardiac imaging helps in evaluating heart function. Similarly, mammography and MRI are vital in breast cancer detection. Traditionally, these analyses rely on expert interpretation, which is time-consuming and costly. The integration of artificial intelligence for automating these tasks promises to reduce healthcare costs and improve patient outcomes.

Methodology

The proposed system reshapes 3D images into two-dimensional (2D) slices, which are processed using a pre-trained feature extractor. A convolutional neural network then analyzes these feature maps to produce a feature vector, leading to biomarker predictions. The system is capable of handling various imaging types, predicting different biomarkers such as drusen volume in OCT images, ejection fraction in ultrasound, hepatic fat fraction in MRI, and nodule malignancy in CT scans. The process involves training the model with annotated datasets to enhance its predictive accuracy.

Training and Model Development

Developing accurate AI models for biomedical imaging requires extensive annotated datasets, which are often scarce. The application addresses this by employing transfer learning, where a model pre-trained on a large dataset of natural images is fine-tuned with a smaller set of medical images. This technique leverages existing knowledge to improve model performance in specific medical tasks, even with limited data. The approach combines both supervised and self-supervised learning methods to enhance the model's ability to generalize across different imaging modalities.

Conclusion

The system represents a significant advancement in the field of medical imaging analysis, providing a scalable solution for automating the diagnosis of disease-related risk factors. By utilizing deep learning and transfer learning, the system offers a robust framework for improving diagnostic accuracy and efficiency. This innovation has the potential to transform clinical workflows, enabling faster and more precise medical interventions, ultimately benefiting patient care and healthcare systems globally.